证券代码：002853 证券简称：皮阿诺 公告编号：2025-030 广东皮阿诺科学艺术家居股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 重要提示： 股，导致公司控股股东、实际控制人马礼斌先生及其一致行动人马瑜霖女士的持 股比例由 38.75%增加至 39.52%；导致公司持股 5%以上股东珠海鸿禄企业管理合 伙企业（有限合伙）及其一致行动人保利（横琴）资本管理有限公司－共青城齐 利股权投资合伙企业（有限合伙）的持股比例由 13.76%增加至 14.03%。 公司因实施注销回购股份导致公司总股本、无限售条件流通股数量发生变化， 根据《中华人民共和国公司法》《中华人民共和国证券法》《深圳证券交易所上 市公司自律监管指引第 9 号——回购股份》等相关规定，现就回购股份注销完成 暨股东权益变动的情况公告如下： 一、本次回购股份的批准及实施情况 公司于 2021 年 5 月 24 日召开第三届董事会第八次会议，审议通过了《关于 回购公司股份方案的议案》，公司拟使用自有资金以集中竞价交易的方式回购公 司股份，并将用于实施公司员工持股计划或者股权激励，回购 ...

Core Viewpoint - The company, Qingdao Haitai Newlight Technology Co., Ltd., has announced the cancellation of 737,000 shares, which represents 0.6110% of the total share capital prior to cancellation, following a decision to change the purpose of repurchased shares from employee stock ownership plans to cancellation and capital reduction [1][2][3]. Group 1: Share Repurchase and Cancellation - The company will cancel 737,000 shares from its repurchase account, reducing the total share capital from 120,614,000 shares to 119,877,000 shares [1][5]. - The cancellation date for the repurchased shares is set for May 13, 2025 [4]. - The repurchase was initially intended for employee stock ownership plans or equity incentives, but the purpose has been changed to cancellation and capital reduction [2][3]. Group 2: Approval and Notification Process - The decision to change the purpose of the repurchased shares and to cancel them was approved at the company's general meeting in March 2025 [2][3]. - The company has complied with legal requirements by notifying creditors about the cancellation and has not received any claims for debt repayment within the stipulated period [3][6]. Group 3: Impact on Company Structure - After the cancellation, the company's total share capital will be 119,877,000 shares, with the shareholding structure remaining compliant with listing requirements [5][6]. - The cancellation is expected to enhance investor confidence and will not significantly impact the company's financial status, operational results, or debt repayment capabilities [6].

证券代码：688186 证券简称：广大特材 公告编号：2025-047 转债代码：118023 转债简称：广大转债 ? 公司控股股东、实际控制人及一致行动人持股数量未发生变化，本次权 益变动不会导致公司控股股东、实际控制人发生变更。 ? 根据《上市公司收购管理办法》《上市公司股份回购规则》的有关规定， 本次权益变动属于可以免于发出要约的情形。 一、本次权益变动基本情况 公司分别于 2025 年 4 月 25 日、2025 年 5 月 12 日召开第三届董事会第十七 次会议、第三届监事会第九次会议、2024 年年度股东大会审议通过了《关于变 更部分回购股份用途并注销的议案》，同意将回购股份用途由"在未来适宜时机 用于股权激励及/或员工持股计划，或用于转换上市公司发行的可转换为股票的 公司债券"变更为"在未来适宜时机用于股权激励及/或员工持股计划，或用于 注销并相应减少注册资本"，并将已回购的股份 8,000,000 股进行注销并相应减少 注册资本。具体内容详见公司分别于 2025 年 4 月 26 日在上海证券交易所网站 （www.sse.com.cn）披露的《关于变更部分回购股份用途并注销暨减少注册资本 的公 ...

Investment Rating - The report assigns a "Buy" rating to the company, indicating that the stock price is expected to outperform the benchmark by more than 15% [14]. Core Views - The company is implementing a share buyback plan with a budget of up to HKD 100 million, which is seen as a catalyst for value recovery and performance release [1][4]. - The board believes the current stock price does not reflect the company's true value and is taking proactive steps to enhance shareholder returns while investing in long-term strategic initiatives [4]. - The company has demonstrated strong confidence in its long-term growth potential, as evidenced by recent share purchases by key executives [4]. Summary by Relevant Sections Company Performance and Market Position - The company has completed its warehousing and supply chain setup, with a cumulative registered buyer base of 827,000 by the end of 2024, including 491,000 pharmacies and 330,000 grassroots medical institutions [5]. - The company is expected to achieve a compound annual growth rate (CAGR) of 145% in net profit from 2024 to 2027, driven by improved profitability from exclusive brand partnerships and economies of scale [5][6]. Financial Projections - Revenue projections for 2025, 2026, and 2027 are approximately HKD 20.81 billion, HKD 23.48 billion, and HKD 26.49 billion, respectively, with year-on-year growth rates of 16%, 13%, and 13% [6][7]. - The net profit attributable to the parent company is expected to reach HKD 1.29 billion, HKD 2.75 billion, and HKD 4.41 billion for the same years, reflecting significant growth rates of 331%, 112%, and 61% [6][7]. Competitive Landscape - The company is navigating challenges in the pharmacy sector, including store closures, but is focusing on expanding its market share among grassroots medical institutions, which may provide new growth channels [5]. - The company has established a competitive edge through its supply chain and digital capabilities, positioning itself well against traditional distributors and e-commerce giants in the B2B pharmaceutical market [5].

遥望科技（002291）公告，公司拟将存放于回购专用证券账户中原计划"员工持股计划或股权激励计 划"的股份之用途变更为"用于注销以减少注册资本"。本次变更事项尚需提交公司股东大会审议。公司 于2022年4月12日召开第五届董事会第二次会议，审议通过了《关于以集中竞价方式回购公司股份方案 的议案》，同意使用自有资金以集中竞价交易的方式回购公司股份，用于实施股权激励计划或员工持股 计划，回购股份的种类为公司发行的人民币普通股(A股)。本次回购股份资金总额不低于人民币1.5亿元 (含)且不超过人民币3亿元(含)，回购股份价格不超过人民币25元/股(含)。截至目前，公司通过回购专用 证券账户以集中竞价交易方式累计回购公司股份856.75万股，占公司回购完成时总股本的0.94%，最高 成交价为21.89元/股，最低成交价为13.41元/股，成交总金额为人民币1.51亿元(不含交易费用)。 ...

公司的第五期股份回购计划也正稳步实施，回购资金总额为不低于1.25亿元，不超过2.50亿元；回购价 格为不超过9.00元/股；截至3月31日，公司通过回购专用证券账户以集中竞价交易方式累计回购(第五 期)股份数约2924.08万股，占公司总股本的0.80%。 此外，公司控股股东浙江恒逸集团有限公司(以下简称"恒逸集团")也积极顺应监管趋势，推出增持股份 计划。截至4月8日，恒逸集团通过深圳证券交易所集中竞价交易系统，已累计增持公司股票约3934.74 万股，占公司总股本的1.07%，目前增持计划仍在有序推进中。 在当前市场环境下，恒逸石化"注销回购股份+现金分红+股份回购+股东增持"多措并举，赢得了资本市 场的高度认可。 本报讯(记者王镜茹见习记者刘晓一)4月28日晚间，恒逸石化（000703）股份有限公司(以下简称"恒逸石 化")发布公告，公司拟注销约6370.38万股回购股份，占公司总股本的1.74%。同时，恒逸石化发布2025 年一季报。第一季度，公司实现营业收入271.68亿元，归属于上市公司股东的净利润5149.48万元。 恒逸石化始终将股东利益放在重要位置。公告显示，基于对公司未来发展前景的信心和 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及其董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大 遗漏。 特别提示： 1、郑州千味央厨食品股份有限公司（以下简称"公司"）本次注销的股份数量为2,102,700股，占公司本 次注销前总股本的2.12%。本次回购股份注销完成后，公司总股本由99,263,146股变更为97,160,446股。 2、公司已于2025年4月23日在中国证券登记结算有限责任公司深圳分公司办理完毕上述回购股份的注销 手续。 根据《深圳证券交易所股票上市规则》、《深圳证券交易所上市公司自律监管指引第9号一一回购股 份》等相关规定，现将公司本次回购股份注销完成暨股份变动的具体情况公告如下： 一、回购股份的实施情况 证券代码：001215 证券简称：千味央厨 公告编号：2025-016 郑州千味央厨食品股份有限公司 关于回购股份注销完成 暨股份变动的公告 公司于2024年4月26日召开第三届董事会第十四次会议，于2024年5月17日召开2023年年度股东大会，审 议通过了《关于以集中竞价交易方式回购公司股份方案的议案》，同意公司拟使用自有资金以集中竞价 ...

Core Viewpoint - Beijing Wantong New Development Group Co., Ltd. has announced the cancellation of part of its repurchased shares, totaling 26,728,000 shares, which will reduce the company's registered capital and total share capital [1][2][4]. Group 1: Decision Process - The decision to cancel the repurchased shares was approved during the board meeting on February 19, 2025, and the shareholders' meeting on March 7, 2025 [1][2]. - The company has complied with legal requirements by notifying creditors regarding the share cancellation, with no objections received [2]. Group 2: Cancellation Details - The cancellation of shares is based on the provisions of the Company Law and relevant regulations, as the repurchased shares were not utilized for employee stock ownership plans or equity incentives within the three-year period [2][3]. - The total number of shares being canceled is 26,728,000 [3]. Group 3: Impact on Company Structure - Following the cancellation, the company's total share capital will decrease from 1,943,644,076 shares to 1,916,916,076 shares [4]. - The cancellation process is expected to be completed by April 23, 2025, and will not adversely affect the company's financial status or operational results [4].

来伊份（603777）公告，公司拟回购注销员工持股计划股份164.65万股，回购价格为7.65元/股，资金约 1259.6万元，资金来源为自有资金。回购完成后，公司股份总数将由3.37亿股减少为3.35亿股，注册资 本将由人民币3.37亿元减少为3.35亿元。此次回购及注销不会对公司财务状况、经营成果和未来发展产 生不利影响，也不会对公司的债务履行能力、持续经营能力及股东权益产生影响。 ...

证券代码：688543 证券简称：国科军工 公告编号：2025-016 国科军工: 关于变更回购股份用途并注销暨减少注 册资本的公告 关于变更回购股份用途并注销 暨减少注册资本的公告 江西国科军工集团股份有限公司 重要内容提示： ? 为提高公司长期投资价值，提升每股收益水平，进一步增强投资者信心， 结合公司实际情况，江西国科军工集团股份有限公司（以下简称"公司"）拟将 存放于回购专用证券账户中的股票 1,666,533 股的用途进行调整，由"用于员工 持股计划或股权激励"变更为"用于注销并减少注册资本"。 ? 注销回购专用证券账户中的 1,666,533 股后，公司总股本将由 175,701,557 股减少为 174,035,024 股，注册资本将由 175,701,557.00 元减少为 174,035,024.00 元。 ? 本次变更回购股份用途并注销暨减少注册资本事项尚需提交公司股东大 会审议通过后实施。 为持续践行"以投资者为本"的发展理念，与投资者共享经营发展成果，推 动上市公司高质量发展和投资价值提升，公司拟将存放于回购专用证券账户中的 股票 1,666,533 股予以注销暨减少注册资本。 本事项 ...